+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Clinical Trial Supplies Market by Product Type, Phase, Indication, Packaging Type, Distribution Channel, Trial Type - Global Forecast to 2030- Product Image
Clinical Trial Supplies Market by Product Type, Phase, Indication, Packaging Type, Distribution Channel, Trial Type - Global Forecast to 2030- Product Image
Sale

Clinical Trial Supplies Market by Product Type, Phase, Indication, Packaging Type, Distribution Channel, Trial Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924676
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior leaders in clinical research face unprecedented supply chain complexities as shifting regulations, patient-centric trial models, and advanced logistics solutions redefine global requirements for clinical trial supplies. Optimizing these critical processes is now imperative for competitive advantage.

Market Snapshot: Clinical Trial Supplies Market

The clinical trial supplies market expanded from USD 3.64 billion in 2024 to USD 3.96 billion in 2025, driven by innovation, regulatory changes, and new distribution strategies. With a compound annual growth rate of 8.45%, the market is expected to reach USD 5.92 billion by 2030. This steady growth indicates rising trial complexity and escalating demand for reliable, compliant supply solutions across geographies, therapeutic areas, and sponsor needs.

Scope & Segmentation of Clinical Trial Supplies

This analysis covers the global landscape, offering critical insight into clinical trial supplies by product, trial phase, indication, packaging, distribution, trial type, and region. Strategic segmentation ensures tailored recommendations for procurement, clinical, and supply chain leaders.

  • Product Types: Ancillaries; Frozen Supplies; Refrigerated Supplies; Room Temperature Supplies. Each entails different logistics and risk mitigation protocols, from cryogenic insulation to basic storage.
  • Trial Phases: Phase I, II, III, IV. Scale, regulatory scrutiny, and supply requirements shift across development stages, influencing inventory strategies and distribution models.
  • Therapeutic Indications: Cardiovascular, Central Nervous System, Infectious Diseases, Oncology. Diseases with unique product and handling needs determine supply chain agility.
  • Packaging Types: Ampoules, Bottles, Cartridges, Pre-Filled Syringes, Vials. Material and configuration impact sterility validation and shipment efficiency.
  • Distribution Channels: Direct Shipment, In-House Logistics (Cold Chain Management, Standard Logistics), Third Party Logistics (Non-Temperature-Controlled, Temperature-Controlled). These models define flexibility, compliance, and delivery timing.
  • Trial Types: Interventional and Observational. Operational differences shape regulatory and logistics priorities.
  • Regions Covered: Americas (including the United States with key states, as well as Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, and others), Asia-Pacific (China, India, Japan, Australia, and more). Each region introduces distinct compliance and infrastructure challenges.
  • Key Players Profiled: Thermo Fisher Scientific Inc., Catalent, Inc., IQVIA Holdings Inc., Syneos Health, Inc., Parexel International Corporation, PCI Pharma Services, Inc., Marken Limited, DHL International GmbH, Almac Group Limited, Envigo RMS, Inc.

Key Takeaways for Senior Decision-Makers

  • Technological advancement is creating end-to-end visibility and control, with real-time temperature monitoring, digital platforms, and predictive analytics now integral for risk mitigation and compliance in clinical trial supplies.
  • Decentralized and hybrid trial designs are shifting logistics strategies from centralized depots to direct-to-patient delivery, demanding modular packaging and agile supplier partnerships to adapt to patient needs and site variability.
  • Environmental sustainability is a rising strategic priority, with sponsors incorporating biodegradable packaging and investing in carbon-efficient logistics to meet compliance and corporate responsibility mandates.
  • Close collaboration between sponsors, contract research organizations, and third-party logistics specialists enables better inventory forecasting, reduced waste, and improved supply reliability, especially in multi-site and international studies.
  • Regional supply chain diversification, including investment in nearshoring and domestic packaging hubs, helps mitigate risks posed by trade disputes or policy changes and strengthens resilience against disruption.

Tariff Impact on Clinical Trial Supplies

The 2025 U.S. tariffs have imposed new cost pressures on critical clinical trial inputs, increasing unit costs for imported items such as specialty packaging components and cold chain equipment. These changes are influencing routing decisions, buffer stock requirements, and working capital allocation. Some sponsors are pursuing nearshoring, renegotiating supplier terms, or leveraging bonded warehouses to address increased costs and uncertainties associated with tariff policy developments.

Methodology & Data Sources

This report synthesizes insights from in-depth interviews with senior supply chain and clinical operations leaders across regions, together with reviews of peer-reviewed journals, guidance documents, and proprietary logistics data. Cross-validation, peer review, and scenario analysis underpin the methodological rigor to ensure actionable and reliable conclusions.

Why This Report Matters

  • Delivers market intelligence tailored for strategic planning, risk identification, and investment in digital and sustainable clinical trial supply chains.
  • Enables procurement and operational executives to benchmark best practices and inform decisions through multi-level segmentation, regional comparisons, and competitive landscape analysis.
  • Guides proactive resilience building by highlighting emerging regulatory, environmental, and trade-related risks and adaptation strategies.

Conclusion

Robust clinical trial supply strategies now require cross-functional collaboration, regional diversification, and innovation adoption. Senior leaders will drive competitive value by aligning sourcing, logistics, and sustainability imperatives with evolving market requirements.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Clinical Trial Supplies Market, by Product Type
8.1. Introduction
8.2. Ancillaries
8.3. Frozen Supplies
8.4. Refrigerated Supplies
8.5. Room Temperature Supplies
9. Clinical Trial Supplies Market, by Phase
9.1. Introduction
9.2. Phase I
9.3. Phase II
9.4. Phase III
9.5. Phase IV
10. Clinical Trial Supplies Market, by Indication
10.1. Introduction
10.2. Cardiovascular
10.3. Central Nervous System
10.4. Infectious Diseases
10.5. Oncology
11. Clinical Trial Supplies Market, by Packaging Type
11.1. Introduction
11.2. Ampoules
11.3. Bottles
11.4. Cartridges
11.5. Pre-Filled Syringes
11.6. Vials
12. Clinical Trial Supplies Market, by Distribution Channel
12.1. Introduction
12.2. Direct Shipment
12.3. in-House Logistics
12.3.1. Cold Chain Management
12.3.2. Standard Logistics
12.4. Third Party Logistics
12.4.1. Non-Temperature-Controlled Logistics
12.4.2. Temperature-Controlled Logistics
13. Clinical Trial Supplies Market, by Trial Type
13.1. Introduction
13.2. Interventional
13.3. Observational
14. Americas Clinical Trial Supplies Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Clinical Trial Supplies Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Clinical Trial Supplies Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Catalent, Inc.
17.3.3. IQVIA Holdings Inc.
17.3.4. Syneos Health, Inc.
17.3.5. Parexel International Corporation
17.3.6. PCI Pharma Services, Inc.
17.3.7. Marken Limited
17.3.8. DHL International GmbH
17.3.9. Almac Group Limited
17.3.10. Envigo RMS, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CLINICAL TRIAL SUPPLIES MARKET MULTI-CURRENCY
FIGURE 2. CLINICAL TRIAL SUPPLIES MARKET MULTI-LANGUAGE
FIGURE 3. CLINICAL TRIAL SUPPLIES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CLINICAL TRIAL SUPPLIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ANCILLARIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY FROZEN SUPPLIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REFRIGERATED SUPPLIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ROOM TEMPERATURE SUPPLIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY AMPOULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DIRECT SHIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COLD CHAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STANDARD LOGISTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NON-TEMPERATURE-CONTROLLED LOGISTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TEMPERATURE-CONTROLLED LOGISTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INTERVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY OBSERVATIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 60. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 62. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 64. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 65. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 66. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 70. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 72. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 107. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 109. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 111. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 113. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 114. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 115. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 121. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 122. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 131. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 133. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 135. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 137. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 138. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 139. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 141. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 143. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 145. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 146. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 171. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 173. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 175. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 177. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 178. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 187. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 189. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 190. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 191. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 193. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 194. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 195. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 197. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 198. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 199. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 201. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 202. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 219. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 221. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 222. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 223. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 225. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 226. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 227. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 229. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 230. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 231. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 233. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 234. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 243. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 245. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 246. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 247. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 249. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 250. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 251. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 253. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 254. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 255. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 257. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 258. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 276. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 278. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 279. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 280. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 282. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 283. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 284. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 286. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 287. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 288. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 290. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 291. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 292. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 294. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 295. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 296. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 298. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 299. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IN-HOUSE LOGISTICS, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2030 (USD MILLION)
TABLE 323. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TRIAL TYPE, 2018-2030 (USD MILLION)
TABLE 324. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 325. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 326. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 327. THAILAND CLINICAL TRIAL SUPPLIES

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Clinical Trial Supplies market report include:
  • Thermo Fisher Scientific Inc.
  • Catalent, Inc.
  • IQVIA Holdings Inc.
  • Syneos Health, Inc.
  • Parexel International Corporation
  • PCI Pharma Services, Inc.
  • Marken Limited
  • DHL International GmbH
  • Almac Group Limited
  • Envigo RMS, Inc.

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.96 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.92 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Clinical Trial Supply & Logistics for Pharmaceutical Market by Service Type, End User, Phase, Transportation Mode, Temperature Range, Packaging Type - Global Forecast to 2030 - Product Image

Clinical Trial Supply & Logistics for Pharmaceutical Market by Service Type, End User, Phase, Transportation Mode, Temperature Range, Packaging Type - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Clinical Trial Supply & Logistics Market by Services, Sourcing Model, Type, Mode of Delivery, End-user, Therapeutic Area, Phases of Clinical Trials - Global Forecast to 2030 - Product Image

Clinical Trial Supply & Logistics Market by Services, Sourcing Model, Type, Mode of Delivery, End-user, Therapeutic Area, Phases of Clinical Trials - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Clinical Trial Supply And Logistics Market Size, Share & Trends Analysis Report By Service (Logistics & Distribution, Storage & Retention), By Phase, By Therapeutic Area (Oncology, Cardiovascular Diseases), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Clinical Trial Supply And Logistics Market Size, Share & Trends Analysis Report By Service (Logistics & Distribution, Storage & Retention), By Phase, By Therapeutic Area (Oncology, Cardiovascular Diseases), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 119 Pages
  • Global
From
Clinical Trial Supplies Market by Services (Manufacturing, Sourcing, Packaging, Labelling, Logistics), Phases, Type (Small Molecules, Biologics, Vaccines), Therapeutic Areas (Oncology, Neurology, CVD, Ophthalmology, Dermatology) - Global Forecast to 2030 - Product Image

Clinical Trial Supplies Market by Services (Manufacturing, Sourcing, Packaging, Labelling, Logistics), Phases, Type (Small Molecules, Biologics, Vaccines), Therapeutic Areas (Oncology, Neurology, CVD, Ophthalmology, Dermatology) - Global Forecast to 2030

  • Report
  • 415 Pages
  • Global
From
Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By End Use, By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By End Use, By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.